In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
Dee Mathieson, Managing Director at Elekta Ltd, believes that NHS budgets need to directly address the cancer backlog - which remains the second largest cause of death, globally.
Małgorzata Anna Bogusz, Rapporteur of the EESC opinion SOC/677 – Europe’s beating cancer plan, argues here that the EU needs a new Marshall Plan for oncology.
A non-invasive test for the early detection of oesophageal cancer has been developed by a team of researchers at the Medical Research Council (MRC) Cancer Cell Unit and is now being rolled out across Scotland.
With the current focus on public health worldwide, Arthur Goudena, Marketing Manager of PHC Europe, explains how one of Europe’s leading biobanks plays a growing role in supporting medical research.
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
Jean-Pierre Leburton, and Olgica Milenkovic, Professors of Electrical and Computer Engineering at the University of Illinois at Urbana-Champaign, discuss how big data processing via bio-sensing, and blue energy production revolutionise solid-state nanopores.
European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.
Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.
